The Great Health System Shakeup: Mergers, Consolidations, and What’s Next

Traditional diligence finds liabilities. Strategic diligence determines whether the combined operating model can deliver the thesis. Build one enterprise process with accountable workstreams, common assumptions, a secure data environment, issue escalation, and an integrated risk register. Finance, clinical leadership, operations, quality, compliance, legal, human resources, technology, cybersecurity, privacy, revenue cycle, real estate, insurance, tax, communications, and community leadership should contribute.

Start with competition and regulatory pathways. Define relevant services, geographies, patient flows, payer alternatives, physician supply, referral relationships, entry barriers, and the practical effect on buyers and patients. Review federal requirements and the state laws applicable to the parties, including any notice, waiting period, attorney general, health agency, charitable-asset, or public-hearing process. Requirements change, so counsel should confirm the rules and filing sequence for the specific structure and closing date. The operating plan should not depend on conduct that regulators or a consent order may restrict.

Examine clinical quality at the level where variation lives. Review mortality, complications, readmissions, infection, safety events, accreditation findings, peer review, credentialing, staffing, transfer performance, service-line outcomes, patient experience, equity, and unresolved corrective actions. Look beyond reported averages to denominator integrity, coding changes, small samples, and trends by facility and population. Identify which quality systems can be harmonized quickly and which require protected local workflows until evidence supports change.

Assess access and network impact. Map where patients obtain primary, specialty, emergency, inpatient, post-acute, behavioral, maternity, and home-based care. Determine whether the transaction could close a gap, create travel burden, change referral patterns, or increase dependence on a single provider. Model capacity, appointment availability, transportation, language access, disability access, digital alternatives, and out-of-network consequences. Service closure assumptions should be explicit even if no closure is planned at signing.

Financial diligence needs an auditable baseline. Normalize earnings for temporary relief, one-time gains, underinvestment, unusual contract terms, pension or benefit items, malpractice, leases, physician subsidies, revenue-cycle performance, cost-report issues, grants, and deferred maintenance. Reconcile capital plans to facility condition and clinical strategy. Validate cash, debt, restrictions, covenants, swaps, leases, pensions, insurance, tax-exempt bonds, donor restrictions, and contingent liabilities. Distinguish recurring value from accounting presentation.

Test every synergy through an owner, action, investment, timing, dependency, and patient-impact lens. Avoid double counting, such as assuming labor savings from both centralized functions and unexplained productivity. Include stranded cost, retention, severance, contract termination, system conversion, consultants, training, travel, rebranding, integration staff, and temporary productivity loss. Assign confidence levels and separate signed contractual savings from behavioral assumptions.

Workforce diligence should examine more than headcount. Review vacancies, turnover, agency use, spans of control, pay practices, collective bargaining, benefits, retirement obligations, medical-staff arrangements, noncompetes where applicable, credentialing, licensure, immigration dependencies, leadership depth, succession, culture, engagement, safety climate, and pending claims. Identify roles essential to safe transition and fund retention selectively. Broad promises of no change can undermine credibility when the operating model is still being designed.

Technology diligence must reach infrastructure and contracts. Inventory applications, interfaces, data models, identity systems, medical devices, networks, hosting, licenses, vendor concentration, technical debt, end-of-life systems, disaster recovery, backups, security findings, privacy restrictions, AI tools, and pending implementations. Verify whether licenses and business associate arrangements transfer. Estimate the cost and clinical disruption of convergence, not only the preferred future platform.

Compliance diligence should include billing and coding, physician arrangements, referral relationships, exclusion screening, research, pharmacy, controlled substances, privacy, security, cost reporting, grants, tax exemption, environmental obligations, and open audits or investigations. Use appropriate legal protocols for sensitive findings. A representation or escrow may allocate economic risk, but it does not remove the need to protect patients and correct ongoing conduct.

Finally, test cultural compatibility with observable evidence. Compare how decisions are made, bad news travels, clinicians influence policy, performance is managed, capital is allocated, and local leaders are held accountable. Survey language about shared values is less useful than reviewing real choices during stress. Identify where one organization expects centralized standards and the other expects local discretion. That difference will surface in almost every integration decision.

Close is not the outcome. Establish a public-value scorecard that reflects the transaction thesis and the concerns raised during review. Cover quality, safety, access, affordability, experience, workforce, community investment, capital, and financial resilience. Show baselines, targets, timing, definitions, and performance by relevant facility or population. Explain material changes in methods rather than presenting incomparable trends.

Keep community accountability connected to governance. Use advisory structures with defined information, access to decision makers, and a response process. Publish progress on enforceable and voluntary commitments. If circumstances require a proposed change, explain the evidence, alternatives, affected populations, mitigation, and decision process before the outcome is irreversible. Engagement cannot guarantee agreement, but it can improve facts and legitimacy.

Monitor competition and access after close. Track commercial and public-payer contracting behavior, patient travel, out-of-network use, appointment availability, service migration, referrals, site-of-care shifts, and physician supply. Review price, total-cost, and utilization effects where valid data exist. Boards should understand whether market power is being translated into investment and better care or merely higher unit revenue and complexity.

Evaluate whether the combined portfolio still fits strategy. Some services need investment and growth; others need partnership, redesign, consolidation, or responsible exit. Use consistent criteria that include mission, community need, quality, workforce, capital, financial performance, alternatives, and transition risk. Cross-subsidy can be intentional, but it should be visible and periodically reviewed.

Conduct formal post-transaction reviews at 12, 24, and 36 months. Compare actual outcomes with the original board record, no-deal baseline, approval assumptions, community commitments, and integration budget. Identify which benefits were realized, which risks emerged, and which capabilities remain incomplete. Adjust leadership incentives and capital allocation to favor verified enterprise value over deal volume or announced synergy.

The review should also shape future transactions. Preserve diligence findings, integration lessons, vendor performance, regulatory commitments, and decision rationales in a controlled repository. Develop a repeatable playbook without assuming the next partner or market will be the same. An organization that learns from one transaction becomes more selective, faster at integration, and more credible when it says no.